eMedicine Specialties > Pediatrics: General Medicine > Dermatology

Epidermolysis Bullosa

Author: Surasak Puvabanditsin, MD, Assistant Professor of Pediatrics, UMDNJ-New Jersey Medical School; Associate Professor of Pediatrics, St George's University School of Medicine, Grenada; Associate Professor of Pediatrics, Seton Hall University School of Graduate Medical Education
Coauthor(s): Eugene Garrow, MD, Chief of Pediatric Surgery, Jersey City Medical Center; Associate Professor, Department of Surgery, Mount Sinai School of Medicine; Rungtiwa Weerasethsiri, MD, Staff Physician, Department of Pediatrics, Mount Sinai School of Medicine, New Jersey; Alexis A D'Elia, BA, St George's University School of Medicine, Grenada; Nisha Patel, BA, St George's University School of Medicine
Contributor Information and Disclosures

Updated: Jun 13, 2007

Introduction

Background

Epidermolysis bullosa (EB) is a rare group of inherited disorders that manifests as blistering or erosion of the skin and, in some cases, the epithelial lining of other organs, in response to little or no apparent trauma.

Categorizations of the types of EB were once controversial and often confusing because more than 20 types of EB have been described. However, major subtypes of EB are recognized: EB simplex (EBS), junctional EB (JEB), and dystrophic EB (DEB). These major subtypes depend on the precise ultrastructural level at which the split responsible for blistering occurs.

The 3 main types of EB were clinically and histologically delineated by the 1960s. In the 1970s, electron microscopy revealed abnormal epidermal keratin filaments in EBS, disordered dermal anchoring fibrils in DEB, and defective hemidesmosomes in JEB. Antigens identified with immunohistochemistry in the 1980s led to discovery of the major EB genes in the 1990s. The identified genes included those that encode keratins 5 and 14 in EBS, collagen VII in DEB, and laminin 5 in Herlitz JEB. Toward the end of millennium, as the complex structure of desmosomes and hemidesmosomes was unraveled, the genes responsible for the rare subtypes were found, including those that encode α6β4 integrin in EB with pyloric atresia, plectin in EB with muscular dystrophy, and plakophilin in EB with ectodermal dysplasia.

Eponyms associated with different forms of EB include the following:

  • Dowling-Meara
  • Köbner
  • Weber-Cockayne
  • Kallin
  • Mendes de Costa
  • Herlitz
  • Ogna
  • Carmi
  • Cockayne-Touraine
  • Pasini
  • Hallopeau-Siemens

Pathophysiology

Cytolysis causes blisters in the epidermis or basement membrane zone of the skin. In EBS, cytolysis causes blisters in the basal or spinous layers of the epidermis, and keratinocytes often have abnormal density and organization of keratin filaments.

In JEB, the epidermis separates from the basal lamina, forming a blister cavity in the plane of the lamina lucida, where hemidesmosome structure and density are frequently diminished.

In DEB, the basal lamina remains attached to the epidermis, but the blister cavity forms beneath the lamina densa of dermoepidermal junction, and anchoring fibrils may appear abnormal, reduced in number, or altogether absent.

Frequency

United States

The exact prevalence of EB is unknown. Mild variants have been estimated to occur as frequently as 1 per 50,000 births. The more severe varieties are believed to occur in 1 per 500,000 births annually.

Mortality/Morbidity

Depending on the type of EB, disease severity may range from occasional mild blistering of the hands and feet to severe and widespread formation of bullae. These lesions may result in nonhealing erosions, infection, scarring, and joint contracture. Mortality is also related to the abnormalities or anomalies associated with EB.

  • Healing of DEB results in dystrophic or scarring change.
  • In EBS, when blisters cleave in the epidermis, healing occurs without scarring.
  • In JEB, when blisters cleave below the epidermis but above the basal lamina, blistering leads to mild atrophic changes.

Race

The EBS Ogna variant was described in Norwegian individuals.

Sex

EB is an autosomal inherited disorder. The incidence does not differ by sex.

Age

  • The onset of EBS occurs at birth or early infancy.
  • The onset of JEB occurs at birth.
  • The onset of DEB occurs at birth or early childhood.

Clinical

History

Important findings in general include the age of onset; the size, frequency, and location of blisters; and the possible inciting factors (eg, heat, trauma).

Check for a family history of blistering disease and for the patient's geographic and racial ancestry. Evaluation of any patient with suspected epidermolysis bullosa (EB) should include mapping of the family's pedigree. However, an absence of affected family members does not, by itself, establish that the mode of transmission is autosomal recessive because apparently isolated cases can be due to spontaneous mutation or incomplete penetrance of an autosomal dominant trait.

Review of systems should include a search for mucosal involvement, including oral, nasopharyngeal, ocular, genitourinary, GI, and respiratory symptoms.

Physical

Perform a complete physical examination with emphasis on inspecting all skin areas and mucosal surfaces. Evaluate the size, location, and character of the blisters and determine the level at which to slit them. Examine the patient for involvement of the nails, hair, or teeth. Areas prone to blistering due to pressure, trauma, or excessive heating include the fingers, hands, elbows, feet, legs, and diaper area (in infants) (see Images 1-5).


Congenital localized absence of skin is now known to be a phenotypic pattern that neonates with any major form of EB may demonstrate at birth (see Image 6-7).

Causes

  • Genetics

    • EBS is an autosomal dominant disorder.
    • JEB is an autosomal recessive disorder.
    • DEB is either autosomal dominant or autosomal recessive.
  • Types of EB and Associated Characteristics 

    Open table in new window

    Table
    Type of EBFeature on Light MicroscopyFeature on Electron MicroscopyProtein or AntigenGene
    EBS (Dowling-Meara)EpidermisKeratin filamentsKeratin 5KRT5
    EBS (Weber-Cockayne)EpidermisKeratin filamentsKeratin 14KRT14
    EB with ectodermal dysplasiaEpidermisDesmosome, attachment plaquePlakophilinPKP1
    EB with muscular dystrophyEpidermisHemidesmosome lamina lucida, attachment plaquePlectinPLEC1
    Non-Herlitz JEBBasement membrane zoneHemidesmosome lamina lucida, subbasal dense plate, anchoring filamentsCollagen XVIIBPAG2
    JEB with pyloric atresiaBasement membrane zoneHemidesmosome lamina lucida, subbasal dense plate, anchoring filamentsAlpha6beta4 integrinITGB6, ITBG4
    Herlitz JEB, rarely non-Herlitz JEBBasement membrane zoneLamina densaLaminin 5LAMA3, LAMB3, LAMC2
    DEBDermisAnchoring fibrilsCollagen VIICOL7A1
    Type of EBFeature on Light MicroscopyFeature on Electron MicroscopyProtein or AntigenGene
    EBS (Dowling-Meara)EpidermisKeratin filamentsKeratin 5KRT5
    EBS (Weber-Cockayne)EpidermisKeratin filamentsKeratin 14KRT14
    EB with ectodermal dysplasiaEpidermisDesmosome, attachment plaquePlakophilinPKP1
    EB with muscular dystrophyEpidermisHemidesmosome lamina lucida, attachment plaquePlectinPLEC1
    Non-Herlitz JEBBasement membrane zoneHemidesmosome lamina lucida, subbasal dense plate, anchoring filamentsCollagen XVIIBPAG2
    JEB with pyloric atresiaBasement membrane zoneHemidesmosome lamina lucida, subbasal dense plate, anchoring filamentsAlpha6beta4 integrinITGB6, ITBG4
    Herlitz JEB, rarely non-Herlitz JEBBasement membrane zoneLamina densaLaminin 5LAMA3, LAMB3, LAMC2
    DEBDermisAnchoring fibrilsCollagen VIICOL7A1

More on Epidermolysis Bullosa

Overview: Epidermolysis Bullosa
Differential Diagnoses & Workup: Epidermolysis Bullosa
Treatment & Medication: Epidermolysis Bullosa
Follow-up: Epidermolysis Bullosa
Multimedia: Epidermolysis Bullosa
References

References

  1. Ayman T, Yerebakan O, Ciftcioglu MA, Alpsoy E. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma. Pediatr Dermatol. Sep-Oct 2002;19(5):436-8. [Medline].

  2. Bart BJ. Epidermolysis bullosa and congenital localized absence of skin. Arch Dermatol. Jan 1970;101(1):78-81. [Medline].

  3. Bart BJ, Gorlin RJ, Anderson VE, Lynch FW. Congenital localized absence of skin and associated abnormalities resembling epidermolysis bullosa. A new syndrome. Arch Dermatol. Mar 1966;93(3):296-304. [Medline].

  4. Bart BJ, Lussky RC. Bart syndrome with associated anomalies. Am J Perinatol. Oct 2005;22(7):365-9. [Medline].

  5. Bello YM, Falabella AF, Schachner LA. Management of epidermolysis bullosa in infants and children. Clin Dermatol. Jul-Aug 2003;21(4):278-82. [Medline].

  6. Butler DF, Berger TG, James WD, et al. Bart's syndrome: microscopic, ultrastructural, and immunofluorescent mapping features. Pediatr Dermatol. Feb 1986;3(2):113-8. [Medline].

  7. Cetinkursun S, Ozturk H, Celasun B, Sakarya MT, Alpasian F. Epidermolysis bullosa associated with pyloric, esophageal, and anal atresia: a case report. J Pediatr Surg. Oct 1995;30(10):1477-8. [Medline].

  8. Chang CH, Perrin EV, Bove KE. Pyloric atresia associated with epidermolysis bullosa: special reference to pathogenesis. Pediatr Pathol. Oct-Dec 1983;1(4):449-57. [Medline].

  9. Christiano AM, Bart BJ, Epstein EH Jr, Uitto J. Genetic basis of Bart's syndrome: a glycine substitution mutation in type VII collagen gene. J Invest Dermatol. Apr 1996;106(4):778-80. [Medline].

  10. Cooper TW, Bauer EA. Epidermolysis bullosa: a review. Pediatr Dermatol. Jan 1984;1(3):181-8. [Medline].

  11. Cowton JA, Beattie TJ, Gibson AA, et al. Epidermolysis bullosa in association with aplasia cutis congenita and pyloric atresia. Acta Paediatr Scand. Jan 1982;71(1):155-60. [Medline].

  12. Dank JP, Kim S, Parisi MA, et al. Outcome after surgical repair of junctional epidermolysis bullosa-pyloric atresia syndrome: a report of 3 cases and review of the literature. Arch Dermatol. Oct 1999;135(10):1243-7. [Medline].

  13. Das BB, Sahoo S. Dystrophic epidermolysis bullosa. J Perinatol. Jan 2004;24(1):41-7. [Medline].

  14. Duran-McKinster C, Rivera-Franco A, Tamayo L, et al. Bart syndrome: the congenital localized absence of skin may follow the lines of Blaschko. Report of six cases. Pediatr Dermatol. May-Jun 2000;17(3):179-82. [Medline].

  15. Eady RA. Epidermolysis bullosa: scientific advances and therapeutic challenges. J Dermatol. Nov 2001;28(11):638-40. [Medline].

  16. Fine JD. Inherited Epidermolysis Bullosa: Selected Outcomes and a Revised Classification System. Pediatr Dermatol. Jan 2000;17(1):75-83. [Medline].

  17. Fine JD, Bauer EA, Briggaman RA, et al. Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol. Jan 1991;24(1):119-35. [Medline].

  18. Fivenson DP, Scherschun L, Choucair M, et al. Graftskin therapy in epidermolysis bullosa. J Am Acad Dermatol. Jun 2003;48(6):886-92. [Medline].

  19. Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. Apr 1986;14(4):646-60. [Medline].

  20. Hayashi AH, Galliani CA, Gillis DA. Congenital pyloric atresia and junctional epidermolysis bullosa: a report of long-term survival and a review of the literature. J Pediatr Surg. Nov 1991;26(11):1341-5. [Medline].

  21. Herod J, Denyer J, Goldman A, Howard R. Epidermolysis bullosa in children: pathophysiology, anaesthesia and pain management. Paediatr Anaesth. Jun 2002;12(5):388-97. [Medline].

  22. Horn HM, Tidman MJ. The clinical spectrum of dystrophic epidermolysis bullosa. Br J Dermatol. Feb 2002;146(2):267-74. [Medline].

  23. Hurwitz S. Clinical Pediatric Dermatology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1993:432-5.

  24. Kanzler MH, Smoller B, Woodley DT. Congenital localized absence of the skin as a manifestation of epidermolysis bullosa. Arch Dermatol. Aug 1992;128(8):1087-90. [Medline].

  25. Kodama Y, Kawamoto M, Iwashita K, et al. Congenital pyloric atresia. A report on a successfully treated case and existing research. Nippon Ika Daigaku Zasshi. Aug 1986;53(4):409-15. [Medline].

  26. Lepinard C, Descamps P, Meneguzzi G, et al. Prenatal diagnosis of pyloric atresia-junctional epidermolysis bullosa syndrome in a fetus not known to be at risk. Prenat Diagn. Jan 2000;20(1):70-5. [Medline].

  27. Lestringant GG, Akel SR, Qayed KI. The pyloric atresia-junctional epidermolysis bullosa syndrome. Report of a case and review of the literature. Arch Dermatol. Aug 1992;128(8):1083-6. [Medline].

  28. Mallipeddi R. Epidermolysis bullosa and cancer. Clin Exp Dermatol. Nov 2002;27(8):616-23. [Medline].

  29. McGrath JA, McMillan JR, Dunnill MG, et al. Genetic basis of lethal junctional epidermolysis bullosa in an affected fetus: implications for prenatal diagnosis in one family. Prenat Diagn. Jul 1995;15(7):647-54. [Medline].

  30. Melhem RE, Salem G, Mishalany H, Slim M, Der Kaloustian VM. Pyloro-duodenal atresia. A report of three families with several similarly affected children. Pediatr Radiol. Jan 24 1975;3(1):1-5. [Medline].

  31. Moore CC. Congenital gastric outlet obstruction. J Pediatr Surg. Dec 1989;24(12):1241-6. [Medline].

  32. Moss C. Skin and kin. J R Soc Med. May 2005;98(5):200-2. [Medline].

  33. Muller M, Morger R, Engert J. Pyloric atresia case report of four cases and review of the literature. Pediatr Surg Int. 1990;5 vol:276-9.

  34. Okoye BO, Parikh DH, Buick RG, Lander AD. Pyloric atresia: five new cases, a new association, and a review of the literature with guidelines. J Pediatr Surg. Aug 2000;35(8):1242-5. [Medline].

  35. Pai S, Marinkovich MP. Epidermolysis bullosa: new and emerging trends. Am J Clin Dermatol. 2002;3(6):371-80. [Medline].

  36. Pearson RW. Clinicopathologic types of epidermolysis bullosa and their nondermatological complications. Arch Dermatol. May 1988;124(5):718-25. [Medline].

  37. Pfendner EG, Nakano A, Pulkkinen L, Christiano AM, Uitto J. Prenatal diagnosis for epidermolysis bullosa: a study of 144 consecutive pregnancies at risk. Prenat Diagn. Jun 2003;23(6):447-56. [Medline].

  38. Pulkkinen L, Christiano AM, Airenne T, et al. Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet. Mar 1994;6(3):293-7. [Medline].

  39. Puvabanditsin S, Garrow E, Kim DU, Tirakitsoontorn P, Luan J. Junctional epidermolysis bullosa associated with congenital localized absence of skin, and pyloric atresia in two newborn siblings. J Am Acad Dermatol. Feb 2001;44(2 Suppl):330-5. [Medline].

  40. Rodeck CH, Eady RA, Gosden CM. Prenatal diagnosis of epidermolysis bullosa letalis. Lancet. May 3 1980;1(8175):949-52. [Medline].

  41. Rowe MI, O'Neill JA, Grosfeld JL. Essential of Pediatric Surgery. St Louis, Mo: Mosby; 1995:486, 501-2.

  42. Rubin AI, Garzon MC, Morel KD. Herpetic infection in epidermolysis bullosa. Pediatr Dermatol. Jul-Aug 2006;23(4):355-7. [Medline].

  43. Schober-Flores C. Epidermolysis bullosa: a nursing perspective. Dermatol Nurs. Aug 1999;11(4):243-8, 253-6. [Medline].

  44. Shaw DW, Fine JD, Piacquadio DJ, et al. Gastric outlet obstruction and epidermolysis bullosa. J Am Acad Dermatol. Feb 1997;36(2 Pt 2):304-10. [Medline].

  45. Skoven I, Drzewiecki KT. Congenital localized skin defect and epidermolysis bullosa hereditaria letalis. Acta Derm Venereol. 1979;59(6):533-7. [Medline].

  46. Smith LT. Ultrastructural findings in epidermolysis bullosa. Arch Dermatol. Dec 1993;129(12):1578-84. [Medline].

  47. Swinburne L, Kohler HG. Symmetrical congenital skin defects in sibs. Arch Dis Child. 1968;43:499.

  48. Teran Ac, Cobo BJ, Guijarro MG. Atrsia de piloro en un recien nacido con epidermolisis ampullosa. Bol Catedra Padiatr (Madrid). 1972;1647-78.

  49. Tong L, Hodgkins PR, Denyer J, et al. The eye in epidermolysis bullosa. Br J Ophthalmol. Mar 1999;83(3):323-6. [Medline].

  50. Uitto J, Christiano AM. Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases. J Clin Invest. Sep 1992;90(3):687-92. [Medline].

  51. Uitto J, Pulkkinen L. Molecular genetics of heritable blistering disorders. Arch Dermatol. Nov 2001;137(11):1458-61. [Medline].

  52. Uitto J, Richard G. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification. Clin Dermatol. Jan-Feb 2005;23(1):33-40. [Medline].

  53. Vidal F, Aberdam D, Miquel C, et al. Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet. Jun 1995;10(2):229-34. [Medline].

  54. Wojnarowska FT, Eady RA, Wells RS. Dystrophic epidermolysis bullosa presenting with congenital localized absence of skin: report of four cases. Br J Dermatol. Apr 1983;108(4):477-83. [Medline].

  55. Yan EG, Paris JJ, Ahluwalia J, Lane AT, Bruckner AL. Treatment decision-making for patients with the Herlitz subtype of junctional epidermolysis bullosa. J Perinatol. May 2007;27(5):307-11. [Medline].

  56. Yiasemides E, Walton J, Marr P, Villanueva EV, Murrell DF. A comparative study between transmission electron microscopy and immunofluorescence mapping in the diagnosis of epidermolysis bullosa. Am J Dermatopathol. Oct 2006;28(5):387-94. [Medline].

  57. Zelickson B, Matsumura K, Kist D, Epstein EH Jr, Bart BJ. Bart's syndrome. Ultrastructure and genetic linkage. Arch Dermatol. Jun 1995;131(6):663-8. [Medline].

Further Reading

Keywords

epidermolysis bullosa, EB, bullous disorder, blister, blistering, skin erosion, epidermolysis bullosa simplex, EBS, junctional epidermolysis bullosa, JEB, dystrophic epidermolysis bullosa, DEB, Herlitz junctional EB, pyloric atresia, ectodermal dysplasia, Dowling-Meara, Köbner, Weber-Cockayne, Kallin, Mendes de Costa, Ogna, Carmi, Cockayne-Touraine, Pasini, Hallopeau-Siemens

Contributor Information and Disclosures

Author

Surasak Puvabanditsin, MD, Assistant Professor of Pediatrics, UMDNJ-New Jersey Medical School; Associate Professor of Pediatrics, St George's University School of Medicine, Grenada; Associate Professor of Pediatrics, Seton Hall University School of Graduate Medical Education
Surasak Puvabanditsin, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Coauthor(s)

Eugene Garrow, MD, Chief of Pediatric Surgery, Jersey City Medical Center; Associate Professor, Department of Surgery, Mount Sinai School of Medicine
Disclosure: Nothing to disclose.

Rungtiwa Weerasethsiri, MD, Staff Physician, Department of Pediatrics, Mount Sinai School of Medicine, New Jersey
Rungtiwa Weerasethsiri, MD is a member of the following medical societies: American Academy of Pediatrics
Disclosure: Nothing to disclose.

Alexis A D'Elia, BA, St George's University School of Medicine, Grenada
Disclosure: Nothing to disclose.

Nisha Patel, BA, St George's University School of Medicine
Nisha Patel, BA is a member of the following medical societies: American Medical Student Association/Foundation and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Kevin P Connelly, DO, Clinical Assistant Professor, Department of Pediatrics, Division of General Pediatrics and Emergency Care, Virginia Commonwealth University; Medical Director, Paws for Health Pet Visitation Program
Kevin P Connelly, DO is a member of the following medical societies: American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine.com, Inc
Disclosure: Nothing to disclose.

Managing Editor

Robert A Schwartz, MD, MPH, Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, Professor of Pathology, Professor of Preventive Medicine and Community Health, UMDNJ-New Jersey Medical School
Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi
Disclosure: Nothing to disclose.

CME Editor

Merrily P M Poth, MD, Professor, Department of Pediatrics and Neuroscience, Uniformed Services University of the Health Sciences
Merrily P M Poth, MD is a member of the following medical societies: American Academy of Pediatrics, Endocrine Society, and Lawson-Wilkins Pediatric Endocrine Society
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.